Perspective Therapeutics, Inc.
CATX- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000728387
In the last 90 days, Perspective Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 131 institutions reported holding it in 13F filings for Q2 2026, worth $297.6M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Perspective Therapeutics, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 135 | 1 | 112 | −22 |
| Shares | 47.3M | 722.0K | 45.3M | −1.26M (−2.7%) |
| Value | $150.7M | $2.30M | $96.4M | −$52.0M (−35.0%) |
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (14)
Institutions that held Perspective Therapeutics, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Nuveen, LLC | 1,242,542 | $2.65M | 0.00% |
| Vestor Capital, LLC | 974,720 | $2.08M | 0.17% |
| Renaissance Technologies LLC | 163,460 | $348.2K | 0.00% |
| Federated Hermes, Inc. | 135,061 | $287.7K | 0.00% |
| Bridgeway Capital Management, LLC | 125,000 | $266.3K | 0.01% |
| Virtus Investment Advisers, Inc. | 47,307 | $100.8K | 0.03% |
| Man Group plc | 15,763 | $33.6K | 0.00% |
| Quadrature Capital Ltd | 15,158 | $32.4K | 0.00% |
| CIBC World Markets Corp | 11,995 | $25.5K | 0.00% |
| Thurston, Springer, Miller, Herd & Titak, Inc. | 117 | $249 | 0.00% |
| Point72 (DIFC) Ltd | 60 | $127 | 0.00% |
| EverSource Wealth Advisors, LLC | 21 | $45 | 0.00% |
| True Wealth Design, LLC | 15 | $32 | 0.00% |
| GWM Advisors LLC | 5 | $11 | 0.00% |
Sold out (36)
Institutions that held Perspective Therapeutics, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
Not filed for Q1 2025 yet (1)
Institutions that held Perspective Therapeutics, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nuveen Asset Management, LLC | 722,048 | $2.30M |